-
1
Orphan RNAs identified as cancer-specific indicators.
-
2
Detectable in blood, offering liquid biopsy potential.
-
3
May act as oncogenic drivers in cancer.
-
4
Distinct from standard gene annotations.
-
5
Enhance sensitivity in cancer detection assays.
-
6
Relevant for uncertain primary cancers.
-
7
Could reveal cancer-subtype signatures.
-
8
Need for further studies on treatment response relationships.
Original Source(s)
A New Molecular Barcode for Cancer?
Pan-cancer analysis identifies cancer-specific small RNAs with tissue-of-origin and liquid biopsy potential
March 4, 2026
-
2 min
Related Content
Overcoming the Challenges of AI Antibody Analysis
Cracking the molecular code
by Ben Holland
February 4, 2026
-
6 min
Errant Cell Division Can Lead to Changes in Gene Activity, Study Finds
There are several ways to ruin a tune: play the wrong notes, play them at the wrong time, or with the wrong emphasis.
by Rob Levy
August 2, 2023
-
9 min
COVID-19 and Kidney Disease: Researchers Identify Overlap Between Biomarkers of the Virus and Renal Cell Carcinoma
A review of COVID-19 literature could lead to effective simultaneous treatment of both diseases
by n/a
March 2, 2021
-
2 min
